Cagrilintide 10mg

Cagrilinitide is a long-acting synthetic amylin analogue engineered for extended receptor engagement at amylin (AMY1–3), calcitonin (CTR), and CGRP receptors. Originally developed as a complement to GLP-1 receptor agonist therapy, cagrilinitide has been studied in combination regimens for its additive effects on appetite suppression, gastric emptying delay, and glucagon inhibition. Its extended half-life of approximately seven days enables once-weekly dosing paradigms in preclinical research models.

Molecular Information

Target Receptors	AMY1–3, Calcitonin (CTR), CGRP
Approximate Half-Life	~7 days
Purity	≥98% (HPLC)
Appearance	White lyophilized powder
Storage Form	Lyophilized peptide
Storage Information	Store in a refrigerated environment free of exposure to sunlight, moisture, or excessive heat.

Mechanisms of Research Interest

Cagrilinitide activates amylin receptors in the area postrema and nucleus tractus solitarius, reducing post-prandial glucagon secretion and slowing gastric emptying to extend satiety. Hypothalamic appetite regulation occurs via AMY receptor-mediated signaling in the arcuate nucleus. In combination with GLP-1 receptor agonists, dual hormonal pathway activation has demonstrated synergistic reductions in body weight and glycemic parameters in preclinical models — supporting the investigational framework for combination metabolic therapies.

Research Applications

Cagrilinitide 10mg is of significant interest in obesity research, type 2 diabetes modeling, beta-cell preservation studies, and combination hormonal therapy investigations. Its extended pharmacokinetic profile makes it particularly well-suited for longitudinal preclinical studies examining sustained modulation of energy balance and glucose homeostasis.

Quality Assurance & Supplier Commitment

We maintain longstanding relationships with leading peptide lyophilizers and raw material suppliers, selected through an exhaustive vetting process that evaluates manufacturing practices, analytical capabilities, and regulatory compliance. Our API sourcing protocol includes certificate of analysis review, third-party analytical testing, and periodic supplier audits to ensure consistent purity, potency, and sterility standards across all product lines.

Each batch undergoes meticulous quality control verification prior to release, including HPLC purity analysis, mass spectrometry confirmation, and endotoxin testing where applicable. Our commitment to sourcing integrity ensures researchers receive material of the highest available quality.

RESEARCH USE ONLY DISCLAIMER

This product is intended exclusively for in vitro research and laboratory use by qualified professionals. It is not approved for human or veterinary use, consumption, or therapeutic application. This product has not been evaluated by the FDA or any equivalent regulatory authority. The seller makes no claims regarding its safety, efficacy, or suitability for any medical, diagnostic, or therapeutic purpose. All research must comply with applicable local, state, and federal regulations.